Literature DB >> 6124754

Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition.

J di Costanzo, N Cano, J Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6124754     DOI： 10.1016/s0140-6736(82)90314-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

2.  Historical perspectives in the care of patients with enterocutaneous fistula.

Authors:  Jonathan B Lundy; Josef E Fischer
Journal:  Clin Colon Rectal Surg       Date:  2010-09

3.  Failure of somatostatin or an analog to promote closure of end pancreatic fistulae.

Authors:  B M Miller; L W Traverso; P C Freeny; N N Abumrad
Journal:  Int J Pancreatol       Date:  1989-02

4.  Effect of somatostatin 14 on pure human pancreatic secretion.

Authors:  L Gullo; P Priori; C Scarpignato; F Baldoni; G Mattioli; L Barbara
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

Review 5.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

6.  Resolution of refractory pancreatic ascites after continuous infusion of octreotide acetate.

Authors:  I A Munshi; R Haworth; P S Barie
Journal:  Int J Pancreatol       Date:  1995-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.